• Bestatin Hydrochloride: From Enzyme to Biology

  2026-09-24

  Bestatin hydrochloride offers translational researchers a way to probe how aminopeptidase activity shapes both tumor-associated phenotypes and peptide signaling. This article connects mechanistic evidence to experimental strategy, clarifies the limits of cross-domain interpretation, and outlines how to build stronger, more informative studies.

• Z-YVAD-FMK for Cell-Death Assay Design

  2026-09-24

  Use Z-YVAD-FMK to test whether caspase-1 activity contributes to inflammatory signaling or cell death—without mistaking that result for evidence of ferroptosis. This practical workflow pairs target-engagement checks with careful vehicle controls and draws a clear boundary between caspase-1 biology and the DGLA–ACSL4 findings in acute myeloid leukemia.

• Rotenone: Mitochondrial Complex I Inhibitor Guide

  2026-09-23

  Rotenone is a mitochondrial Complex I inhibitor used to study electron-transport disruption, oxidative stress, and cell-death responses. This guide summarizes the B5462 product information, reported model-specific observations, and practical limits for interpreting rotenone experiments.

• Glucocorticoids, Kv2.1, and CaV1.2 Signaling

  2026-09-23

  The reference study identifies a rapid, non-genomic pathway by which glucocorticoids suppress CaV1.2-mediated calcium signals in hippocampal neurons. Its central innovation is linking reduced cAMP–PKA activity to endocytosis of Kv2.1 channel clusters, which in turn promotes loss of surface CaV1.2 channels.

• Rimonabant (SR141716) in CB1 Research

  2026-09-22

  Rimonabant (SR141716) provides a selective CB1 blockade strategy for separating receptor-driven effects from vehicle, locomotor, sex, and stress-related confounders. This workflow-focused guide connects withdrawal models with appetite regulation research, cell assays, and inflammation studies while emphasizing formulation and interpretation controls.

• (-)-Epigallocatechin gallate (EGCG) Assay Guide

  2026-09-22

  A scenario-based guide to using (-)-Epigallocatechin gallate (EGCG), SKU A2600, in cell viability, proliferation, cytotoxicity, and apoptosis workflows. It addresses solvent compatibility, assay interference, dose selection, cross-domain interpretation, and practical vendor evaluation.

• 10 mM dNTP Mixture for DNA Synthesis

  2026-09-21

  Learn how an equimolar 10 mM dNTP mixture improves reproducibility across PCR, qPCR, sequencing preparation, and defined DNA-cargo workflows. This practical guide connects nucleotide control with recent evidence that cholesterol can hinder lipid nanoparticle trafficking, while separating validated findings from assay-development recommendations.

• HyperScribe™ K1068: mRNA for In Vivo CAR-T

  2026-09-21

  Explore how HyperScribe™ K1068 supports CD19 CAR mRNA workflows for in vivo CAR-T research, with emphasis on capping, 5-moUTP incorporation, poly(A) design, and assay-quality decisions. The article connects mRNA chemistry to findings from a recent lupus model without overstating product validation.

• TCEP Hydrochloride for Capture-and-Release Assays

  2026-09-20

  Tris(2-carboxyethyl) phosphine hydrochloride can do more than reduce protein disulfides. This article examines how TCEP hydrochloride may support cleavable-linker workflows, assay architecture, and redox-sensitive sample preparation while distinguishing established evidence from application-specific validation.

• Cefotaxime as a Lens on Resistance Gene Transfer

  2026-09-19

  Cefotaxime can connect antimicrobial phenotype with beta-lactamase activity, plasmid mobility, and bacterial lineage. This article translates a 2025 CREC transmission study into a phenotype-to-genotype assay strategy without confusing in vitro selection with clinical diagnosis.

• Wortmannin in Cell Assays: Practical Guide

  2026-09-18

  Learn how Wortmannin (SKU A8544) can improve the design and interpretation of PI3K-dependent cell viability, proliferation, and apoptosis experiments. This scenario-driven guide covers mechanism, solvent compatibility, concentration planning, off-target interpretation, and practical product-selection criteria.

• DEBIO 1143 in Triple-Negative Breast Cancer

  2026-09-18

  The reference study combines cell-based assays with molecular docking and 1-μs molecular dynamics simulations to examine how DEBIO 1143 affects murine triple-negative breast cancer models. Its central finding is that cIAP1 depletion is associated with reduced apoptotic death and increased necroptosis-like and autophagy-associated responses, while the simulations suggest these downstream changes are cellular consequences rather than direct binding to RIP3, Beclin-1, or LC3II.

• From Epigenetic Choice to Sensitive Tissue Imaging

  2026-09-17

  The TRIM66 study reveals how olfactory neurons enforce one-receptor expression through epigenetic repression. This article translates that mechanistic insight into a practical imaging strategy, showing how TSA-based Cy3 amplification can help researchers visualize low-abundance proteins and nucleic acids while preserving spatial context in fixed cells and tissues.

• Mitochondrial TERC-53 Signaling in Cellular Senescence

  2026-09-17

  The reference study identifies mitochondrion-processed TERC-53 as a non-coding RNA signal that links mitochondrial status to cellular senescence and age-associated cognitive decline without changing telomerase activity. Its gain- and loss-of-function experiments provide a framework for studying organelle-to-nucleus communication independently of canonical telomere maintenance.

• Leucovorin Calcium in Gastric Cancer Assembloids

  2026-09-16

  Leucovorin Calcium, or calcium folinate, can be used as both a methotrexate rescue reagent and a mechanistic probe in patient-derived gastric cancer assembloids. This article outlines how folate rescue can help distinguish tumor-intrinsic antifolate sensitivity from stromal modulation while improving translational assay design.

7737 records 1/516 page Next 12345 下5页 Last page